MXPA04006545A - Nuevas formas de dosificacion farmaceutica y metodo para producir las mismas. - Google Patents

Nuevas formas de dosificacion farmaceutica y metodo para producir las mismas.

Info

Publication number
MXPA04006545A
MXPA04006545A MXPA04006545A MXPA04006545A MXPA04006545A MX PA04006545 A MXPA04006545 A MX PA04006545A MX PA04006545 A MXPA04006545 A MX PA04006545A MX PA04006545 A MXPA04006545 A MX PA04006545A MX PA04006545 A MXPA04006545 A MX PA04006545A
Authority
MX
Mexico
Prior art keywords
dosage forms
pharmaceutical dosage
producing same
novel pharmaceutical
mixture
Prior art date
Application number
MXPA04006545A
Other languages
English (en)
Inventor
Allan J Clarke
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of MXPA04006545A publication Critical patent/MXPA04006545A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J3/00—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms
    • A61J3/10—Devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms into the form of compressed tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J2200/00—General characteristics or adaptations
    • A61J2200/20—Extrusion means, e.g. for producing pharmaceutical forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)

Abstract

Se producen formas de dosificacion farmaceuticas, mediante el moldeo por inyeccion de una mezcla de un agente activo y un polimero bajo presion, en la presencia de un gas o un fluido supercritico; la liberacion rapida de la presion causa que la mezcla forme un solido microcelular o supermicrocelular, la liberacion de la presion tiene lugar en el molde; el procedimiento es especialmente util para producir tabletas durables de disolucion instantanea y gastrorretentivas.
MXPA04006545A 2002-01-03 2003-01-03 Nuevas formas de dosificacion farmaceutica y metodo para producir las mismas. MXPA04006545A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34552602P 2002-01-03 2002-01-03
PCT/US2003/000099 WO2003057197A1 (en) 2002-01-03 2003-01-03 Novel pharmaceutical dosage forms and method for producing same

Publications (1)

Publication Number Publication Date
MXPA04006545A true MXPA04006545A (es) 2004-10-04

Family

ID=23355385

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04006545A MXPA04006545A (es) 2002-01-03 2003-01-03 Nuevas formas de dosificacion farmaceutica y metodo para producir las mismas.

Country Status (11)

Country Link
US (1) US20050202090A1 (es)
EP (1) EP1478345A4 (es)
JP (1) JP2005529844A (es)
CN (1) CN1638741A (es)
AU (1) AU2003206382B2 (es)
BR (1) BR0306717A (es)
CA (1) CA2471948A1 (es)
CO (1) CO5590888A2 (es)
MX (1) MXPA04006545A (es)
NZ (1) NZ533784A (es)
WO (1) WO2003057197A1 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0306717A (pt) * 2002-01-03 2004-12-28 Smithkline Beecham Corp Formas de dosagem farmacêutica e método para a produção das mesmas
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
JP2007505084A (ja) * 2003-09-10 2007-03-08 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 小板として形成される粒子
JP4547161B2 (ja) * 2004-01-22 2010-09-22 エスエス製薬株式会社 用時溶解型速溶性固形製剤
DE102005042875A1 (de) * 2004-12-23 2006-09-21 Grünenthal GmbH Schnell freisetzende Darreichungsformen für Antibiotika
US20060224095A1 (en) * 2005-04-05 2006-10-05 University Of New Hampshire Biocompatible polymeric vesicles self assembled from triblock copolymers
DE102005040251A1 (de) * 2005-08-24 2007-03-01 Boehringer Ingelheim Pharma Gmbh & Co. Kg Transcorneales System zur Abgabe eines Arzneimittel-Wirkstoffes
CA2626802A1 (en) * 2005-11-09 2007-09-20 Novartis Ag Process for making pharmaceutical compositions with a transient plasticizer
US20070196494A1 (en) * 2006-02-17 2007-08-23 Arnaud Grenier Low-friability, patient-friendly orally disintegrating formulations
US20080138404A1 (en) * 2006-12-06 2008-06-12 Biovail Laboratories International S.R.L. Extended release formulations of carvedilol
NZ578204A (en) 2006-12-22 2012-05-25 Ironwood Pharmaceuticals Inc Compositions comprising bile acid sequestrants for treating esophageal disorders
CN101288647B (zh) * 2007-04-18 2012-04-18 王雷波 一种药用微丸丸芯及其制备方法
RU2465916C2 (ru) 2007-10-19 2012-11-10 Оцука Фармасьютикал Ко., Лтд. Твердый фармацевтический препарат матричного типа
WO2009134848A1 (en) * 2008-04-30 2009-11-05 Novartis Ag Continuous process for making pharmaceutical compositions
EP2133071A1 (en) * 2008-06-09 2009-12-16 Université de la Méditerranée Process for making gastroretentive dosage forms
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US20120100212A1 (en) * 2009-07-06 2012-04-26 Kyorin Pharmaceutical, Co., Ltd. Tablet having hollow structure
US20130156720A1 (en) 2010-08-27 2013-06-20 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
CN102058869B (zh) * 2010-12-30 2012-08-22 山西振东开元制药有限公司 一种木香顺气胃漂浮制剂及其制备方法
PL2680815T3 (pl) 2011-03-01 2017-02-28 The Procter & Gamble Company Porowate, ulegające rozpadowi stałe podłoże do zastosowań związanych z higieną osobistą
US20150004213A1 (en) * 2011-12-16 2015-01-01 Vimac Ventures Llc Vaginal Drug Delivery Devices and Manufacturing Methods
HUE045625T2 (hu) * 2013-01-30 2019-12-30 Daewoong Co Ltd Gyógyászati kompozíciók sebek védelmére, vérpangás szolgáltatására, vagy összetapadás megakadályozására a gyomor- és bél traktusban
US20160184230A1 (en) * 2014-04-30 2016-06-30 Aron H. Blaesi Melt-processed polymeric cellular dosage form
JP6570043B2 (ja) 2014-06-02 2019-09-04 クレシオ・バイオサイエンシズ・リミテッド 膨張性胃内滞留型剤形
US9617230B2 (en) 2014-12-22 2017-04-11 Farmington Pharma Development Creatine prodrugs, compositions and methods of use thereof
US11129798B2 (en) * 2016-08-19 2021-09-28 Aron H. Blaesi Fibrous dosage form
JP7071748B2 (ja) 2016-12-02 2022-05-19 クレキシオ バイオサイエンシーズ エルティーディー． 胃内滞留システム
CN111182892A (zh) * 2017-10-02 2020-05-19 诺华股份有限公司 用于生产药物载体的方法
WO2019069108A1 (en) 2017-10-04 2019-04-11 Debreceni Egyetem SOLID GALENIC FORM, MOLDED, GASTRIC RETENTION AND EXTENDED RELEASE AND METHOD OF PREPARING THE SAME
CA3128468A1 (en) 2017-10-05 2019-04-11 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce dux4 and downstream gene expression for the treatment of fshd
US10342786B2 (en) 2017-10-05 2019-07-09 Fulcrum Therapeutics, Inc. P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
SG11202004336VA (en) 2017-12-01 2020-06-29 Ultragenyx Pharmaceutical Inc Creatine prodrugs, compositions and methods of use thereof
EP3720537A1 (en) 2017-12-04 2020-10-14 Clexio Biosciences Ltd. Long acting gastric residence system
CN113499442B (zh) * 2021-08-25 2024-02-09 青岛蓝谷药业有限公司 一种胶囊用新型遮光剂及其制备方法和应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
IN160476B (es) * 1983-02-18 1987-07-11 Warner Lambert Co
DE3612212A1 (de) * 1986-04-11 1987-10-15 Basf Ag Verfahren zur herstellung von festen pharmazeutischen formen
JPH02153945A (ja) * 1988-12-06 1990-06-13 Seiko Instr Inc 多孔質プラスチックの製造方法
JPH03163011A (ja) * 1989-08-31 1991-07-15 Yamanouchi Pharmaceut Co Ltd 胃内滞留デバイス
US5034171A (en) * 1989-11-30 1991-07-23 Air Products And Chemicals, Inc. Process for extruding thermoplastic materials using low pressure inert gases as foaming agents
GB9224557D0 (en) * 1992-11-24 1993-01-13 Cerestar Holding Bv Starch based material
GB9302259D0 (en) * 1993-02-05 1993-03-24 Cerestar Holding Bv Starch based material
DE69428707T2 (de) * 1993-08-20 2002-07-11 Nippon Shinyaku Co Ltd Im magen verbleibende zubereitung, quellender formkörper und herstellungsverfahren
JP3586815B2 (ja) * 1995-03-24 2004-11-10 タキロン株式会社 セル構造体の製造方法
US5710190A (en) * 1995-06-07 1998-01-20 Iowa State University Research Foundation, Inc. Soy protein-based thermoplastic composition for foamed articles
US5766623A (en) * 1996-03-25 1998-06-16 State Of Oregon Acting By And Through The Oregon State Board Of Higher Education On Behalf Of Oregon State University Compactable self-sealing drug delivery agents
DE19635676A1 (de) * 1996-09-03 1998-03-05 Basf Ag Feste geschäumte Wirkstoffzubereitungen
US6650934B2 (en) * 1996-12-17 2003-11-18 Alza Corp Polymeric foam reservoirs for an electrotransport delivery device
DE19733505A1 (de) * 1997-08-01 1999-02-04 Knoll Ag Schnell wirksames Analgeticum
BR0014498A (pt) * 1999-10-05 2002-06-11 Procter & Gamble Artigos elásticos e uso dos mesmos
EP1120109A3 (en) * 2000-01-24 2002-07-10 Pfizer Products Inc. Rapidly disintegrating and fast dissolving solid dosage form
BR0306717A (pt) * 2002-01-03 2004-12-28 Smithkline Beecham Corp Formas de dosagem farmacêutica e método para a produção das mesmas

Also Published As

Publication number Publication date
JP2005529844A (ja) 2005-10-06
CO5590888A2 (es) 2005-12-30
AU2003206382B2 (en) 2008-01-24
EP1478345A4 (en) 2010-11-17
US20050202090A1 (en) 2005-09-15
CN1638741A (zh) 2005-07-13
CA2471948A1 (en) 2003-07-17
WO2003057197A1 (en) 2003-07-17
BR0306717A (pt) 2004-12-28
EP1478345A1 (en) 2004-11-24
NZ533784A (en) 2006-08-31
AU2003206382A1 (en) 2003-07-24

Similar Documents

Publication Publication Date Title
MXPA04006545A (es) Nuevas formas de dosificacion farmaceutica y metodo para producir las mismas.
PH12019501331A1 (en) Direct compression formulation and process
TWI256961B (en) Method of manufacturing polymeric foam using supercritical fluids
KR950700052A (ko) 속용정(Fast soluble tablet)
EP1811007A4 (en) THERMAL SPRAYING MICROBALL, THEIR MANUFACTURE, USE, COMPOSITION, AND PRODUCT CONTAINING THEREOF
AU2002224124A1 (en) Method for producing preparation containing bioactive substance
UA85564C2 (ru) Твердая фармацевтическая форма ингибитора протеазы вич и способ ее получения
TW200716175A (en) Direct compression formulation and process
WO2006058675A3 (de) Modifizierte offenzellige schaumstoffe und verfahren zu ihrer herstellung
JP2005507897A5 (es)
WO2006100281A3 (en) Solubilized ibuprofen
UY32127A (es) Granulado conteniendo nicotina con muy reducida o nula producción de polvo en procesos donde se utilice y procedimientos de preparación
ATE533476T1 (de) Komprimierte pharmazeutische zusammensetzung mit beschichteten pellets und direktes kompressionsgemisch und herstellungsverfahren dafür
PL374041A1 (en) Pharmaceutical composition having a delayed active substance release, and method for the preparation thereof
IL181154A0 (en) Preparation of ultrapure polymeric articles
EA201200727A1 (ru) Фармацевтическая композиция, содержащая гидрохлорид донепезила, полученная из нее таблетка и способ ее получения
WO2008039351A3 (en) Method of manufacturing tablets containing pharmacologically active agents
EA200401418A1 (ru) Способ получения таблеток из фармацевтически активных веществ, имеющих неблагоприятные свойства для таблетирования, с использованием гранулирующей жидкости, содержащей микрокристаллическую целлюлозу
WO2008069938A3 (en) Method of forming a tablet comprising pre-blend of ibupropen and silicon dioxide
CA2648667A1 (en) Sustained-release tablet production process
TNSN05203A1 (fr) Procede pour la fabrication d'une composition pharmaceutique sous la forme de comprimes contenant un fibrate et comprimes obtenus selon le procede
WO2003086362A3 (en) Method of stabilizing bupropion hydrochloride tablets
AU2003273976A1 (en) Device and method for producing physically expanded structural foams during an injection molding process involving the use of dynamic mixing elements
MXPA02009056A (es) Proceso para la preparacion de formulaciones de liberacion acelerada usando fluidos comprimidos.
AU2001239625A1 (en) Method of preparing solid dispersions